170 related articles for article (PubMed ID: 27541441)
1. Electroneutral composite polymersomes self-assembled by amphiphilic polyphosphazenes for effective miR-200c in vivo delivery to inhibit drug resistant lung cancer.
Peng Y; Zhu X; Qiu L
Biomaterials; 2016 Nov; 106():1-12. PubMed ID: 27541441
[TBL] [Abstract][Full Text] [Related]
2. Cationic Polyphosphazene Vesicles for Cancer Immunotherapy by Efficient in Vivo Cytokine IL-12 Plasmid Delivery.
Gao M; Zhu X; Wu L; Qiu L
Biomacromolecules; 2016 Jun; 17(6):2199-209. PubMed ID: 27192398
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.
Liu Q; Li RT; Qian HQ; Wei J; Xie L; Shen J; Yang M; Qian XP; Yu LX; Jiang XQ; Liu BR
Biomaterials; 2013 Sep; 34(29):7191-203. PubMed ID: 23806972
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
[TBL] [Abstract][Full Text] [Related]
5. Polyphosphazene vesicles for co-delivery of doxorubicin and chloroquine with enhanced anticancer efficacy by drug resistance reversal.
Xu J; Zhu X; Qiu L
Int J Pharm; 2016 Feb; 498(1-2):70-81. PubMed ID: 26657275
[TBL] [Abstract][Full Text] [Related]
6. High loading of hydrophilic/hydrophobic doxorubicin into polyphosphazene polymersome for breast cancer therapy.
Xu J; Zhao Q; Jin Y; Qiu L
Nanomedicine; 2014 Feb; 10(2):349-58. PubMed ID: 23969103
[TBL] [Abstract][Full Text] [Related]
7. Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics.
Li X; Zhu X; Qiu L
Acta Biomater; 2016 Apr; 35():269-79. PubMed ID: 26873366
[TBL] [Abstract][Full Text] [Related]
8. Effective intracellular delivery and Th1 immune response induced by ovalbumin loaded in pH-responsive polyphosphazene polymersomes.
Gao M; Peng Y; Jiang L; Qiu L
Nanomedicine; 2018 Jul; 14(5):1609-1618. PubMed ID: 29649590
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
11. Amino-functionalized nano-vesicles for enhanced anticancer efficacy and reduced myelotoxicity of carboplatin.
Zhu X; Peng Y; Qiu L
Colloids Surf B Biointerfaces; 2017 Sep; 157():56-64. PubMed ID: 28575741
[TBL] [Abstract][Full Text] [Related]
12. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor activity of resveratrol and miR-200c in human lung cancer.
Bai T; Dong DS; Pei L
Oncol Rep; 2014 May; 31(5):2293-7. PubMed ID: 24647918
[TBL] [Abstract][Full Text] [Related]
14. Over expression of miR-200c suppresses invasion and restores methotrexate sensitivity in lung cancer A549 cells.
Shan W; Zhang X; Li M; Deng F; Zhang J
Gene; 2016 Nov; 593(2):265-71. PubMed ID: 27432063
[TBL] [Abstract][Full Text] [Related]
15. Nano-vesicles based on phospholipid-like amphiphilic polyphosphazenes to orally deliver ovalbumin antigen for evoking anti-tumor immune response.
Shen Y; Hu Y; Qiu L
Acta Biomater; 2020 Apr; 106():267-277. PubMed ID: 32058081
[TBL] [Abstract][Full Text] [Related]
16. miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1.
Zhou G; Zhang F; Guo Y; Huang J; Xie Y; Yue S; Chen M; Jiang H; Li M
Biomed Pharmacother; 2017 Jan; 85():113-119. PubMed ID: 27930974
[TBL] [Abstract][Full Text] [Related]
17. Infra Red Dye and Endostar Loaded Poly Lactic Acid Nano Particles as a Novel Theranostic Nanomedicine for Breast Cancer.
Zhang Q; Du Y; Jing L; Liang X; Li Y; Li X; Dai Z; Tian J
J Biomed Nanotechnol; 2016 Mar; 12(3):491-502. PubMed ID: 27280247
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of drug resistance reversal in Dox-resistant MCF-7 cells by pH-responsive amphiphilic polyphosphazene containing diisopropylamino side groups.
Qiu L; Zheng C; Zhao Q
Mol Pharm; 2012 May; 9(5):1109-17. PubMed ID: 22494535
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
